Pfizer chief corporate affairs officer Sally Susman is departing the company after roughly two decades, CEO Albert Bourla ...

NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) today announced changes to its executive leadership team to further advance its aspirations to discover and develop new medicines and vaccines ...

Pfizer Inc.PFE-0.50%decrease; red down pointing triangle assigned new leadership roles and jobs to a range of top executives, as the drugmaker prepares for Albert Bourla to begin his tenure as ...

Leadership is about driving change at scale and requires engaging both hearts and minds. Sally Susman, Executive Vice President and Chief Corporate Affairs Officer at Pfizer, provides insights ...

The Justice Department changed its policy on foreign corruption cases, which might have put an end to investigations into the pharmaceutical company.

NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) today announced the executive leadership team for the combined Pfizer and Allergan plc (NYSE: AGN) business following the close of the proposed ...

Pfizer: New CEO, New Strategy, New Focus On Brand Name Drugs In A Year Of Drastic Change Dec. 17, 2019 11:27 AM ET Pfizer Inc. (PFE) Stock BMY , MRK , VTRS , ZTS , JNJ , LLY , PFE 18 Comments 22 Likes ...

Like most companies, Pfizer has a publicly stated purpose: “Breakthroughs that change lives”. Bourla and the Pfizer board delivered on this – big time.

NEW YORK, Dec 6 (Reuters) - Investors hoped a leadership shake-up at Pfizer Inc might bring divestitures, share buybacks or other moves to kick-start the company's sluggish stock price, but they ...

Pfizer Inc. today announced changes to its executive leadership team to further advance its aspirations to discover and develop new medicines and vaccines, with an emphasis on oncology. Under his ...